Our evaluation shows how treatment of COVID-19-related PR, using a steroid therapy (associated with systemic antihistamine and topical moisturizing cream) may accelerate the PR healing process, at the same time, improving the clinical course associated with COVID-19. Lastly, we advocate that during the SARS-CoV-2 pandemic, telemedicine appointments play a very crucial and important role in supporting patients confined to their home.
Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine. literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection / Paolino, G.; Di Nicola, M. R.; Cantisani, C.; Mercuri, S. R.. - In: DERMATOLOGIC THERAPY. - ISSN 1396-0296. - 34:4(2021). [10.1111/dth.14972]
Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine. literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection
Paolino G.;Cantisani C.;
2021
Abstract
Our evaluation shows how treatment of COVID-19-related PR, using a steroid therapy (associated with systemic antihistamine and topical moisturizing cream) may accelerate the PR healing process, at the same time, improving the clinical course associated with COVID-19. Lastly, we advocate that during the SARS-CoV-2 pandemic, telemedicine appointments play a very crucial and important role in supporting patients confined to their home.| File | Dimensione | Formato | |
|---|---|---|---|
|
Paolino_Pityriasi_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
505.29 kB
Formato
Adobe PDF
|
505.29 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
